[Acute blue urticaria following subcutaneous injection of patent blue dye].

Ann Dermatol Venereol

Service de dermatologie-allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France; Sorbonne universités, UPMC université Paris 6, 4, place Jussieu, 75005 Paris, France; Unité fonctionnelle de dermatologie, groupe hospitalier Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France.

Published: November 2015

Background: Patent blue (PB) is a lymphatic vessel dye commonly used in France for sentinel lymph node detection in breast cancer, and less frequently in melanoma, and which may induce hypersensitivity reactions. We report a case of acute blue urticaria occurring within minutes of PB injection.

Patients And Methods: Ten minutes after PB injection for sentinel lymph node detection during breast cancer surgery, a 49-year-old woman developed generalised acute blue urticaria and eyelid angioedema without bronchospasm or haemodynamic disturbance, but requiring discontinuation of surgery. Skin testing using PB and the anaesthetics given were run 6 weeks after the episode and confirmed PB allergy. PB was formally contra-indicated.

Discussion: Immediate hypersensitivity reactions to PB have been reported for between 0.24 and 2.2% of procedures. Such reactions are on occasion severe, chiefly involving anaphylactic shock. Two mechanisms are probably associated: non-specific histamine release and/or an IgE-mediated mechanism. Skin tests are helpful in confirming the diagnosis of PB allergy.

Conclusion: Blue acute urticaria is one of the clinical manifestations of immediate hypersensitivity reactions to patent blue dye. Skin tests must be performed 6 weeks after the reaction in order to confirm the diagnosis and formally contra-indicate this substance.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annder.2015.08.008DOI Listing

Publication Analysis

Top Keywords

blue urticaria
12
patent blue
12
hypersensitivity reactions
12
sentinel lymph
8
lymph node
8
node detection
8
detection breast
8
breast cancer
8
acute blue
8
skin tests
8

Similar Publications

Article Synopsis
  • The study aimed to investigate the impact of combining acupuncture and bloodletting on inflammatory responses in rats diagnosed with urticaria, focusing on serum markers and skin tissue characteristics.
  • Using 42 SD rats, researchers divided them into six groups: a control, a model, a positive drug, an acupuncture, a bloodletting, and a combined treatment group, with specific interventions administered for 14 days.
  • After treatment, the researchers measured various inflammatory markers, assessed the skin damage, and analyzed the activity of mast cells to evaluate the effectiveness and potential mechanisms of this therapy for urticaria.
View Article and Find Full Text PDF

Objectives: To observe the effect of electroacupuncture (EA) preconditioning at "Quchi" (LI11) and "Xuehai" (SP10) in prevention of urticaria.

Methods: Twenty-four male SD rats were randomly divided into control, model and preconditioning of EA (Pre-EA) groups (8 rats/group). The urticaria model was established by intradermal injection of dilute allogeneic antioalbumin serum at the spots of the bilateral symmetry of the spine on the back, and followed by tail venous injection of mixture solution of egg albumin diluent, plus 0.

View Article and Find Full Text PDF

Hydroxychloroquine-induced generalized myopathy in a patient with lupus tumidus: a case report.

Dermatol Reports

June 2024

Rare Dermatological Diseases Unit, Department of Health Sciences, Toscana Centro Local Health Unit, Florence; European Reference Network Skin Member.

A subtype of cutaneous lupus erythematosus known as lupus erythematosus tumidus (LET) is characterized by sun-exposed areas that typically display urticaria-like papules and plaques. For LET, systemic therapy with antimalarials - particularly hydroxychloroquine (HCQ) - is the first line of treatment. Even though the safety profile of these medications appears to be high, there have been very few reports of side effects in the literature, including hemolytic anemia, retinal toxicity, maculopapular rash, gastrointestinal disturbance, and blue-gray discoloration of the skin or mucous membranes.

View Article and Find Full Text PDF

Introduction: Allergic diseases, such as anaphylaxis and urticaria, pose significant health concerns. The quest for improved prognostic outcomes in these diseases necessitates the exploration of novel therapeutic avenues. To address this need, we have developed a novel mouse model of anaphylaxis, denoted as anaphylaxis-dependent spotted distribution of immune complex in skin (ASDIS).

View Article and Find Full Text PDF

Treatment of periorbital veins with vascular laser: A systematic review and retrospective case series.

J Cosmet Dermatol

August 2024

Non surgical aesthetics, Drs Tatiana + Rishi Advanced Aesthetics, Non surgical aesthetics, London, UK.

Introduction: Vascular lasers may represent a promising treatment option for periorbital veins. This article aims to: (1) systematically review the literature on the safety and effectiveness of vascular laser treatment for periorbital veins and (2) assess safety and effectiveness through a retrospective case series.

Methods: Systematic review: Articles that assessed the safety and effectiveness of vascular laser treatment for periorbital veins were included and quality assessed using the Downs and Black checklist.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!